According to Spero Therapeutics's latest financial reports the company's current earnings (TTM) are C$23.79 M. In 2023 the company made an earning of C$31.83 M an increase over its 2022 earnings that were of -C$59.43 M.The earnings displayed on this page is the company's Pretax Income.